Fairmount Funds Management as of Dec. 31, 2020
Portfolio Holdings for Fairmount Funds Management
Fairmount Funds Management holds 18 positions in its portfolio as reported in the December 2020 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Insmed Com Par $.01 (INSM) | 11.5 | $32M | 962k | 33.29 | |
Amicus Therapeutics (FOLD) | 10.9 | $30M | 1.3M | 23.09 | |
Iovance Biotherapeutics (IOVA) | 9.4 | $26M | 566k | 46.40 | |
ACADIA Pharmaceuticals (ACAD) | 8.6 | $24M | 450k | 53.46 | |
Trillium Therapeutics Com New | 7.8 | $22M | 1.5M | 14.71 | |
Allakos (ALLK) | 7.4 | $21M | 148k | 140.00 | |
Zogenix Com New | 7.0 | $20M | 981k | 19.99 | |
Axsome Therapeutics (AXSM) | 6.4 | $18M | 220k | 81.47 | |
Cogent Biosciences (COGT) | 6.3 | $18M | 1.6M | 11.23 | |
Argenx Se Sponsored Adr (ARGX) | 5.3 | $15M | 50k | 294.09 | |
Mirati Therapeutics | 4.8 | $13M | 61k | 219.64 | |
Karyopharm Therapeutics (KPTI) | 3.9 | $11M | 702k | 15.48 | |
Global Blood Therapeutics In | 3.3 | $9.3M | 215k | 43.31 | |
Amarin Corp Spons Adr New (AMRN) | 2.6 | $7.4M | 1.5M | 4.89 | |
Enanta Pharmaceuticals (ENTA) | 2.3 | $6.3M | 150k | 42.10 | |
Seres Therapeutics (MCRB) | 2.3 | $6.3M | 257k | 24.50 | |
Verona Pharma Sponsored Ads (VRNA) | 0.3 | $700k | 100k | 7.00 | |
Miragen Therapeutics Com New | 0.2 | $554k | 35k | 15.79 |